SRY-Box 9–Driven Spasmolytic Polypeptide-Expressing Metaplasia Cell Lineage Plasticity Is a Potential Therapeutic Target That Mitigates Risk of Metaplastic Progression to Gastric Cancer
- DOI
- 10.1053/j.gastro.2026.06.024
- Published
- 2026-07
- Container
- Gastroenterology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1053/j.gastro.2026.06.024,
title = {SRY-Box 9–Driven Spasmolytic Polypeptide-Expressing Metaplasia Cell Lineage Plasticity Is a Potential Therapeutic Target That Mitigates Risk of Metaplastic Progression to Gastric Cancer},
author = {Alexis A. Guenther and Amanda Ruelas and Brianna Caldwell and Youngwon Cho and Changqing Zhang and Bogun Jang and Benjamin C. Duncan and Judith Romero-Gallo and Jonathan T. Busada and Richard Peek and Eunyoung Choi},
year = {2026},
journal = {Gastroenterology},
doi = {10.1053/j.gastro.2026.06.024},
url = {https://doi.org/10.1053/j.gastro.2026.06.024}
}RIS
TY - JOUR TI - SRY-Box 9–Driven Spasmolytic Polypeptide-Expressing Metaplasia Cell Lineage Plasticity Is a Potential Therapeutic Target That Mitigates Risk of Metaplastic Progression to Gastric Cancer AU - Alexis A. Guenther AU - Amanda Ruelas AU - Brianna Caldwell AU - Youngwon Cho AU - Changqing Zhang AU - Bogun Jang AU - Benjamin C. Duncan AU - Judith Romero-Gallo AU - Jonathan T. Busada AU - Richard Peek AU - Eunyoung Choi PY - 2026 JO - Gastroenterology DO - 10.1053/j.gastro.2026.06.024 UR - https://doi.org/10.1053/j.gastro.2026.06.024 ER -
APA
Guenther, A. A., Ruelas, A., Caldwell, B., Cho, Y., Zhang, C., Jang, B., Duncan, B. C., Romero-Gallo, J., Busada, J. T., Peek, R., & Choi, E. (2026). SRY-Box 9–Driven Spasmolytic Polypeptide-Expressing Metaplasia Cell Lineage Plasticity Is a Potential Therapeutic Target That Mitigates Risk of Metaplastic Progression to Gastric Cancer. Gastroenterology. https://doi.org/10.1053/j.gastro.2026.06.024
Source records
- crossref · retrieved 2026-09-27T02:48:06.218Z